Novartis Raises Annual Sales Growth Forecast After Restructuring
Novartis AG raised its mid-term sales growth forecast as the Swiss drugmaker narrows its focus on innovative medicines
2023-11-28 15:56
A Doctor With Brain Cancer Is Helping Transform Its Treatment
When Richard Scolyer was diagnosed with a deadly brain tumor in June, he grasped the test results as
2023-10-14 07:29
Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
2023-06-30 20:53
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20
Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut
When Exondys 51 was approved to treat Duchenne muscular dystrophy, a deadly disease that puts kids in wheelchairs
2023-05-15 07:23